Dr. McArthur Discusses Subpopulation Data from coBRIM Trial in Advanced Melanoma
November 23rd 2019
Grant McArthur, PhD, discusses significant results from the final analysis of the coBRIM trial, which evaluated the 5-year survival data of cobimetinib plus vemurafenib in patients with BRAF V600-mutated advanced melanoma.